Skip to content

Clinical trials

Phase 3 Axial Spondyloarthritis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Axial Spondyloarthritis Phase: Phase 3 Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20131
20154
20164
20174
20195
20201
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
UCB Biopharma SRL3
AbbVie2
Eli Lilly and Company2
Janssen Research & Development, LLC2
UCB BIOSCIENCES GmbH2
AbbVie (prior sponsor, Abbott)1
Alfasigma S.p.A.1
Biocad1
Genrix (Shanghai) Biopharmaceutical Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Axial Spondyloarthritis24
Spondylitis, Ankylosing12
Non-Radiographic Axial Spondyloarthritis6
Arthritis3
Spinal Diseases3
Spondylarthritis3
Spondylarthropathies3
Arthritis, Psoriatic1
Autoimmune Diseases1
Joint Diseases1

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.